-
Abstract Number: 689
Patterns of High Disease Activity Status and Outcomes in Systemic Lupus Erythematosus
-
Abstract Number: 690
Urinary MRP8/14, an Endogenous Toll-Like Receptor 4 Ligand, Reflects Renal Disease Activity in Lupus Nephritis: A Cross-Sectional and Longitudinal Assessment
-
Abstract Number: 691
Adjusted GAPSS in Systemic Lupus Erythematosus Patients in Argentina
-
Abstract Number: 692
Correlation of Urinary Soluble CD163 Levels with Clinicopathological Features in Lupus Nephritis: Its Role as a Potential Biomarker
-
Abstract Number: 693
Hair Chemicals and Systemic Lupus Erythematosus: A Case-Control Study
-
Abstract Number: 694
Body Mass Index at Time of Diagnosis Is Predictive of Future Disease Activity in SLE
-
Abstract Number: 695
Environmental and Atmospheric Factors in Systemic Lupus Erythematosus: A Regression Analysis
-
Abstract Number: 696
The Performance of a Renal Activity Index in Lupus Nephritis in Induction Therapy
-
Abstract Number: 697
Differing Opinions on Clinical Research Between Healthcare Providers and Lupus Patients
-
Abstract Number: 698
Measurement of Type I IFNα Production at the mRNA Level and Its Potential Use as a Biomarker in Systemic Lupus Erythematosus
-
Abstract Number: 699
Revising the SLEDAI-2K to Include Additional Constitutional Symptoms to More Accurately Assess Lupus Disease Activity
-
Abstract Number: 700
Sleep Quality Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 701
Association of Cumulative Urinary Podocyte Number and Urinary Podocalyxin with Long-term Renal Prognosis in Lupus Nephritis
-
Abstract Number: 702
Seasonality of Cutaneous and Systemic Flares in Adults and Children in the Einstein Lupus Cohort
-
Abstract Number: 703
Prior Knowledge Feature Reduction Improves Performance in a Machine Learning Model of Systemic Lupus Erythematosus Flare Status Using Serum Proteomics
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 198
- Next Page »